I choose CCI positive control samples by matching the artificial defect to the leak test method, container-closure system, and quality control objective. The most suitable sample should create a repeatable, detectable challenge without changing the test setup or damaging equipment. I also verify material compatibility, defect location, handling requirements, and traceability before approving it for routine use.
Please visit our website for more information on this topic.
For pharmaceutical, medical device, cosmetic, and other package integrity laboratories, a positive control is not simply a container that has been opened or damaged. It is a controlled reference sample designed to demonstrate that the leak test can detect a defined failure condition. Because the required sensitivity and test configuration vary, I recommend selecting controls through a documented, application-specific process rather than choosing only by price or appearance.
Before selecting a CCI positive control sample, I first identify what the laboratory needs to prove. The objective may be instrument function verification, method suitability, analyst training, routine system suitability, or investigation of an unexpected result. Each objective can require a different control design, even when the same package is being tested.
I document the container type, closure material, sealing process, test method, expected failure mode, and acceptance criteria. I also record whether the test is destructive or nondestructive, because the control must be handled differently in each case. A control intended for routine daily verification may need higher handling durability than one used only during method development.
I do not treat all CCI test methods as interchangeable. Pressure decay, vacuum decay, tracer gas, high-voltage, dye-based, visual, and other techniques respond to different physical conditions. A positive control that is detectable by one method may be unsuitable for another if its defect geometry, material, or location does not create the required signal.
The control should therefore be evaluated under the same basic conditions as the production sample. This includes fixture configuration, test pressure or vacuum, dwell time, temperature, and software settings where applicable. If the laboratory changes one of these factors, I recommend reassessing whether the positive control still provides an appropriate challenge.
A meaningful positive control has a defined failure characteristic rather than an accidental opening. Examples may include a calibrated channel, a controlled seal discontinuity, a puncture, a cap or stopper defect, or another supplier-defined challenge. The correct choice depends on whether the laboratory is studying seal integrity, closure fit, component damage, or a specific package failure mechanism.
Location is equally important. A defect in the seal area may challenge the sealing process, while a defect in the container wall may represent a different risk. I ask the supplier to describe how the defect is created, how it is identified, and whether its position is controlled across supplied units.
I compare the positive control with the actual test article in terms of container material, closure material, geometry, and sealing interface. Glass, plastic, elastomeric, foil, and multilayer structures can respond differently to pressure, vacuum, temperature, solvents, and mechanical handling. A control should challenge the method without introducing an unrelated response caused by incompatible materials.
Compatibility also includes storage and cleaning conditions. If the laboratory uses refrigeration, elevated temperature exposure, disinfectants, or repeated cleaning, I confirm whether these conditions could alter the control. For example, deformation, swelling, surface contamination, or closure movement may change the test response and make the result difficult to interpret.
I normally review the control against three categories: physical fit, test response, and handling stability. Physical fit means that the sample can be loaded into the fixture and processed without modification. Test response means that the defect creates the intended detectable condition. Handling stability means that normal use does not unintentionally change the defect or package configuration.
Where the supplier cannot provide a universal compatibility statement, I use a controlled internal evaluation. A practical starting plan may include 3 consecutive test runs under the intended method conditions, with results recorded by the laboratory. This is a qualification approach, not a guaranteed acceptance requirement, so the final number of runs should follow the laboratory’s quality system and validation protocol.
If you want to learn more, please visit our website Zholion.
A positive control must be detectable consistently enough to support a meaningful quality decision. I look for evidence that the supplied design has a defined defect mechanism, controlled dimensions or configuration where applicable, and an identification system that prevents accidental substitution. I also examine whether the control can distinguish a functioning test system from an instrument that is not responding correctly.
Repeatability does not mean that every laboratory will obtain identical numerical values. Test results can vary with equipment, operators, environmental conditions, and setup. For this reason, I establish an internal baseline during qualification and define what constitutes a pass, fail, or investigation result within the laboratory’s approved procedure.
I use positive controls to challenge the test method, not to replace product specifications or release testing. The control confirms that the system can respond to a selected defect condition, while production samples must still be assessed against their own approved acceptance criteria. Keeping these purposes separate helps prevent overinterpretation of a positive control result.
Handling can influence the performance of a CCI positive control, particularly when the defect is small or located in a critical seal area. I ask whether the sample is reusable, limited-use, or intended for one test sequence only. I also request instructions for transport, storage orientation, cleaning, inspection, and retirement.
For routine laboratory use, I recommend assigning each control a unique identification code and recording its issue date, usage history, condition, and replacement date. A conservative planning example is to review the control after 24 hours of exposure to a defined storage or conditioning environment before approving it for use. The actual conditioning period should be based on the supplier’s instructions and the laboratory’s documented study.
Visual inspection is also useful, but it is not a substitute for the leak test. I check for visible damage, contamination, deformation, closure movement, or changes in the marked identification. If the control’s physical condition changes, I place it on hold until its suitability is evaluated.
| Decision area | What I review | Why it matters |
|---|---|---|
| Technical design | Defect type, location, dimensions, and intended test method | Confirms that the sample challenges the correct failure mode |
| Documentation | Identification, specifications, handling instructions, and lot information | Supports traceability and controlled laboratory use |
| Customization | Container format, closure design, defect configuration, and labeling | Improves relevance to the actual package system |
| Supply planning | Minimum order quantity, lead time, packaging, and replacement availability | Reduces interruption to routine quality control |
I also compare whether the supplier can explain the control’s manufacturing process without making unsupported performance claims. A responsible supplier should distinguish between product specifications, qualification information, and results that must be confirmed by the customer’s own method. This distinction is especially important when the control is used in a regulated laboratory environment.
At Zholion, I approach CCI positive control sample selection as a product and application-matching exercise. I can help organize the required information around the package format, closure system, defect type, test method, handling conditions, and documentation needs. This allows the proposed control to be reviewed against the laboratory’s actual quality control objective rather than treated as a generic accessory.
For an initial inquiry, I recommend providing the container and closure description, test technology, target failure mode, expected usage frequency, storage conditions, and any dimensional or labeling requirements. Zholion can then clarify available product configurations, customization possibilities, packaging, identification, and supply planning. Where application-specific performance must be confirmed, the laboratory should complete its own qualification under approved procedures.
The best CCI positive control sample is the one that creates a relevant, controlled, and repeatable challenge for your specific leak test and container-closure system. I recommend starting with the laboratory objective, then matching the defect mechanism, location, material, test technology, and handling conditions. After that, qualify the control under your documented method and maintain clear records for identification and replacement.
Your next step is to prepare a technical requirement sheet covering the package format, test method, defect characteristics, storage conditions, usage frequency, and documentation expectations. Send that information to Zholion for a focused product and supply discussion. With this structured approach, your laboratory can reduce selection risk and build a more defensible CCI quality control process.
Are you interested in learning more about CCI Positive Control Samples? Contact us today to secure an expert consultation!

Comments
0